Marcus Ferrone, PharmD, JD

InstitutionUniversity of California San Francisco
DepartmentClinical Pharmacy
Address1700 4th St
San Francisco CA 94158
vCardDownload vCard

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Maidens J, Gordon JW, Chen HY, Park I, Van Criekinge M, Milshteyn E, Bok R, Aggarwal R, Ferrone M, Slater JB, Kurhanewicz J, Vigneron DB, Arcak M, Larson PEZ. Spatio-temporally constrained reconstruction for hyperpolarized carbon-13 MRI using kinetic models. IEEE Trans Med Imaging. 2018 Jun 05. PMID: 29994332.
      View in: PubMed
    2. Chen HY, Larson PEZ, Gordon JW, Bok RA, Ferrone M, van Criekinge M, Carvajal L, Cao P, Pauly JM, Kerr AB, Park I, Slater JB, Nelson SJ, Munster PN, Aggarwal R, Kurhanewicz J, Vigneron DB. Technique development of 3D dynamic CS-EPSI for hyperpolarized 13 C pyruvate MR molecular imaging of human prostate cancer. Magn Reson Med. 2018 Mar 25. PMID: 29575178.
      View in: PubMed
    3. Shin J, Tabatabai D, Boscardin C, Ferrone M, Brock T. Integration of a Community Pharmacy Simulation Program into a Therapeutics Course. Am J Pharm Educ. 2018 Feb; 82(1):6189. PMID: 29491500.
      View in: PubMed
    4. Park I, Larson PEZ, Gordon JW, Carvajal L, Chen HY, Bok R, Van Criekinge M, Ferrone M, Slater JB, Xu D, Kurhanewicz J, Vigneron DB, Chang S, Nelson SJ. Development of methods and feasibility of using hyperpolarized carbon-13 imaging data for evaluating brain metabolism in patient studies. Magn Reson Med. 2018 Jan 10. PMID: 29322616.
      View in: PubMed
    5. Ferrone M, Kebodeaux C, Fitzgerald J, Holle L. Implementation of a virtual dispensing simulator to support US pharmacy education. Curr Pharm Teach Learn. 2017 Jul; 9(4):511-520. PMID: 29233422.
      View in: PubMed
    6. Chen HY, Larson PEZ, Bok RA, von Morze C, Sriram R, Delos Santos R, Delos Santos J, Gordon JW, Bahrami N, Ferrone M, Kurhanewicz J, Vigneron DB. Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion. Cancer Res. 2017 06 15; 77(12):3207-3216. PMID: 28428273.
      View in: PubMed
    7. Braun HM, Ramirez D, Zahner GJ, Gillis-Buck EM, Sheriff H, Ferrone M. The LGBTQI health forum: an innovative interprofessional initiative to support curriculum reform. Med Educ Online. 2017; 22(1):1306419. PMID: 28399716.
      View in: PubMed
    8. Hiroko T, Yuki N, Munetoshi S, Wincor MZ, Ferrone M, Kishi D, Motoyoshi N.The effects of short-term clinical pharmacy learning trips on english learning motives in 5th-year pharmacy students. Med Ed Japan. 2017; 4(48):249-55.
    9. Nelson SJ, Kurhanewicz J, Vigneron DB, Larson PE, Harzstark AL, Ferrone M, van Criekinge M, Chang JW, Bok R, Park I, Reed G, Carvajal L, Small EJ, Munster P, Weinberg VK, Ardenkjaer-Larsen JH, Chen AP, Hurd RE, Odegardstuen LI, Robb FJ, Tropp J, Murray JA. Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate. Sci Transl Med. 2013 Aug 14; 5(198):198ra108. PMID: 23946197.
      View in: PubMed
    10. Thomasy SM, Whittem T, Bales JL, Ferrone M, Stanley SD, Maggs DJ. Pharmacokinetics of penciclovir in healthy cats following oral administration of famciclovir or intravenous infusion of penciclovir. Am J Vet Res. 2012 Jul; 73(7):1092-9. PMID: 22738064.
      View in: PubMed
    11. Davis B, Ferrone M. Prokinetic Therapy for Feed Intolerance in Critical Illness: One Drug or Two? Nutr Clin Pract. 2008 Dec; 23(6):660-661. PMID: 29130864.
      View in: PubMed
    12. Ferrone M, Raimondo M, Scolapio JS. Pancreatic enzyme pharmacotherapy. Pharmacotherapy. 2007 Jun; 27(6):910-20. PMID: 17542772.
      View in: PubMed
    13. Ferrone M, Geraci M. A review of the relationship between parenteral nutrition and metabolic bone disease. Nutr Clin Pract. 2007 Jun; 22(3):329-39. PMID: 17507733.
      View in: PubMed
    14. Mayes S, Ferrone M. Fentanyl HCl patient-controlled iontophoretic transdermal system for the management of acute postoperative pain. Ann Pharmacother. 2006 Dec; 40(12):2178-86. PMID: 17164395.
      View in: PubMed
    15. Ferrone M, Scolapio JS. Teduglutide for the treatment of short bowel syndrome. Ann Pharmacother. 2006 Jun; 40(6):1105-9. PMID: 16705029.
      View in: PubMed
    16. Hughes CL, Tan WW, Ferrone M.. Sorafenib for the treatment of renal cell carcinoma. J Pharm Technol. 2006; (22):281-8.
    17. Scolapio JS, Ferrone M, Gillham RA. Urticaria associated with parenteral nutrition. JPEN J Parenter Enteral Nutr. 2005 Nov-Dec; 29(6):451-3. PMID: 16224040.
      View in: PubMed
    18. Ferrone M.. Pharmacotherapeutic options to prevent radiocontrast-induced acute renal failure. Formulary. 2004; (39):163-85.
    19. Ferrone M.. Pharmaceutical interventions in end-stage renal disease. U.S. Pharmacist. 2004; 11(29):HS34-45.
    20. Ferrone M, Motl SE. Trastuzumab for the treatment of non-small-cell lung cancer. Ann Pharmacother. 2003 Dec; 37(12):1904-8. PMID: 14632535.
      View in: PubMed
    21. Ferrone M.. Pharmaceutical interventions in acute renal failure. U.S. Pharmacist. 2003; 10(28):28-39.
    22. Ferrone M, Motl SE.Current pharmacotherapy for the treatment of migraines. U.S. Pharmacist. 2003; 3(28):33-56.